13F Portfolios

Deep Track Capital, LP — VAXCYTE INC PCVX: Quarterly 13F Position History

Deep Track Capital, LP has reported VAXCYTE INC (PCVX) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 4,300,000 shares ($249.9M market value, 5.16% of the equity book). Quarter-over-quarter share count change: + 300,000 (+7.5%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 4,300,000 +300,000 +7.5% $249.9M 5.16% $58.11
Q4 2025 4,000,000 +1,000,000 +33.3% $184.6M 4.21% $46.14
Q3 2025 3,000,000 +850,000 +39.5% $108.1M 3.02% $36.02
Q2 2025 2,150,000 +1,400,000 +186.7% $69.9M 2.25% $32.51
Q1 2025 750,000 $28.3M 0.92% $37.76

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Deep Track Capital, LP first disclose a PCVX position in 13F-HR filings?

Deep Track Capital, LP first reported VAXCYTE INC (PCVX) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.

What was Deep Track Capital, LP's most recent quarter-over-quarter share-count change in PCVX?

Between Q4 2025 and Q1 2026, Deep Track Capital, LP added 300,000 shares of PCVX (+7.5%), bringing the total reported position to 4,300,000 shares at a market value of $249.9M.

Does the implied price-per-share represent Deep Track Capital, LP's cost basis in PCVX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.